Magdalena Kobielarz

Prof. Dr. Magdalena Kobielarz

Department of Mechanics, Materials and Biomedical Engineering, Wrocław University of Science and Technology, 50-370 Wrocław, Poland
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MGMałgorzata Gazińska
Małgorzata Gazińska
AKAnna Krokos
Anna Krokos
Magdalena KobielarzMagdalena Kobielarz
Magdalena Kobielarz
MWMarcin Wlodarczyk
Marcin Wlodarczyk
PSPaulina Skibińska
Paulina Skibińska
KRKarolina Rudnicka
Karolina Rudnicka
Novel biocomposites of poly(L-lactide) (PLLA) and poly(l-lactide-co-glycolide) (PLLGA) with 10 wt.% of surface-modified hydroxyapatite particles, designed for applications in bone tissue engineering, are presented in this paper. The surface of hydroxyapatite (HAP) was modified with polyethylene glycol by using l-lysine as a linker molecule. The modification strategy fulfilled two important goals: improvement of the adhesion between the HAP surface and PLLA and PLLGA matrices, and enhancement of the osteological bioactivity of the composites. The surface modifications of HAP were confirmed by attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), TGA, and elemental composition analysis. The influence of hydroxyapatite surface functionalization on the thermal and in vitro biological properties of PLLA- and PLLGA-based composites was investigated. Due to HAP modification with polyethylene glycol, the glass transition temperature of PLLA was reduced by about 24.5 °C, and melt and cold crystallization abilities were significantly improved. These achievements were scored based on respective shifting of onset of melt and cold crystallization temperatures and 1.6 times higher melt crystallization enthalpy compared with neat PLLA. The results showed that the surface-modified HAP particles were multifunctional and can act as nucleating agents, plasticizers, and bioactive moieties. Moreover, due to the presented surface modification of HAP, the crystallinity degree of PLLA and PLLGA and the polymorphic form of PLLA, the most important factors affecting mechanical properties and degradation behaviors, can be controlled.

1 September 2020 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
Magdalena KobielarzMagdalena Kobielarz
Magdalena Kobielarz
MKMarta Kozuń
Marta Kozuń
MGMarlena Gąsior-Głogowska
Marlena Gąsior-Głogowska
ACAgnieszka Chwiłkowska
Agnieszka Chwiłkowska

Verified
Journal Article
Open access
PDF file
Paweł J. PiszkoPaweł J. Piszko
Paweł J. Piszko
MWMarcin Wlodarczyk
Marcin Wlodarczyk
SZSonia Anna Zielińska
Sonia Anna Zielińska
MGMałgorzata Gazińska
Małgorzata Gazińska
PPPrzemysław Płociński
Przemysław Płociński
Konrad SzustakiewiczKonrad Szustakiewicz
Konrad Szustakiewicz
In this research, we synthesize and characterize poly(glycerol sebacate) pre-polymer (pPGS) (1H NMR, FTiR, GPC, and TGA). Nano-hydroxyapatite (HAp) is synthesized using the wet precipitation method. Next, the materials are used to prepare a PGS-based composite with a 25 wt.% addition of HAp. Microporous composites are formed by means of thermally induced phase separation (TIPS) followed by thermal cross-linking (TCL) and salt leaching (SL). The manufactured microporous materials (PGS and PGS/HAp) are then subjected to imaging by means of SEM and µCT for the porous structure characterization. DSC, TGA, and water contact angle measurements are used for further evaluation of the materials. To assess the cytocompatibility and biological potential of PGS-based composites, preosteoblasts and differentiated hFOB 1.19 osteoblasts are employed as in vitro models. Apart from the cytocompatibility, the scaffolds supported cell adhesion and were readily populated by the hFOB1.19 preosteoblasts. HAp-facilitated scaffolds displayed osteoconductive properties, supporting the terminal differentiation of osteoblasts as indicated by the production of alkaline phosphatase, osteocalcin and osteopontin. Notably, the PGS/HAp scaffolds induced the production of significant amounts of osteoclastogenic cytokines: IL-1β, IL-6 and TNF-α, which induced scaffold remodeling and promoted the reconstruction of bone tissue. Initial biocompatibility tests showed no signs of adverse effects of PGS-based scaffolds toward adult BALB/c mice.

27 August 2020 in Materials
Verified
Journal Article
Open access
PDF file
MTMagdalena Tomanik
Magdalena Tomanik
Magdalena KobielarzMagdalena Kobielarz
Magdalena Kobielarz
Jarosław FilipiakJarosław Filipiak
Jarosław Filipiak
MSMaria Szymonowicz
Maria Szymonowicz
Agnieszka RusakAgnieszka Rusak
Agnieszka Rusak
CPCelina Pezowicz
Celina Pezowicz
Laser-based technologies are extensively used for polymer surface patterning and/or texturing. Different micro- and nanostructures can be obtained thanks to a wide range of laser types and beam parameters. Cell behavior on various types of materials is an extensively investigated phenomenon in biomedical applications. Polymer topography such as height, diameter, and spacing of the patterning will cause different cell responses, which can also vary depending on the utilized cell types. Structurization can highly improve the biological performance of the material without any need for chemical modification. The aim of the study was to evaluate the effect of CO2 laser irradiation of poly(L-lactide) (PLLA) thin films on the surface microhardness, roughness, wettability, and cytocompatibility. The conducted testing showed that CO2 laser texturing of PLLA provides the ability to adjust the structural and physical properties of the PLLA surface to the requirements of the cells despite significant changes in the mechanical properties of the laser-treated surface polymer.

1 March 2018 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
MKMarta Kozuń
Marta Kozuń
Magdalena KobielarzMagdalena Kobielarz
Magdalena Kobielarz
ACAgnieszka Chwiłkowska
Agnieszka Chwiłkowska
CPCelina Pezowicz
Celina Pezowicz

29 October 2012 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
AKAleksandra Kuzan
Aleksandra Kuzan
ACAgnieszka Chwiłkowska
Agnieszka Chwiłkowska
Magdalena KobielarzMagdalena Kobielarz
Magdalena Kobielarz
CPCelina Pezowicz
Celina Pezowicz
AGAndrzej Gamian
Andrzej Gamian
Glycation consists in formation of advanced glycation end-products (AGE) during non-enzymatic reaction between reducing sugars and proteins, lipids or nucleic acids. This review is focused mainly on glycation of collagen and its role in acceleration of vascular disease. Collagen is an extracellular matrix protein characterized by unique structure forming fibrils with great anti-tensile and anti-breaking strength. The protein builds the connective tissue and is responsible for biomechanical properties of blood vessels. It is reported that higher content of glycated collagen correlates with lower elasticity and greater toughness of the vessel walls and, as a consequence, a faster rate of atherosclerosis development. Numerous mechanisms connected with AGE formation are involved in atherogenesis, among others: receptor-mediated production of free radicals, triggering an inflammatory process, activation of leukocytes and thrombocytes, facilitation of LDL binding, change in level of growth factors, adhesion molecules, MMP and some other proteins' expression. The coverages allow the development of therapeutic strategies to prevent or slow down the pathological processes connected with glycation of collagen and other proteins in the artery wall. The main strategies are based on limitation of exogenous AGE, consumption of products which contain rutin, treatment with drugs which inhibit AGE formation, such as pyridoxamine, and chemicals which are able to cleave already formed AGE protein-protein crosslinks, such as ALT-711.